AdaptHealth (AHCO) Insider III Buys 18,999 Shares

Insider Buying and Selling at AdaptHealth Corp.

On June 24, 2026, David Solomon III bought 18,999 shares of AdaptHealth Corp. (NasdaqCM: AHCO). This purchase adds to a series of insider transactions that day, as several executives also acquired the same number of shares.

A Growing Trend Among Insiders

This marks a notable trend, as Solomon's purchase follows similar buys by other insiders, including Gregory Belinfanti, Terence Connors, Theodore Lundberg, Bradley Coppens, and Susan Weaver, each acquiring 18,999 shares on the same date. This collective buying activity may signal confidence in the company's future prospects, although the specific motivations behind these transactions remain unclear.

Stock Performance and Market Context

AdaptHealth's stock recently traded at $10.18, which is above its 52-week low of $5.21. The stock has seen a high of $13.43 in the past year, indicating some volatility. The share price is noteworthy as it approaches the average price targets set by analysts, reflecting potential investor interest moving forward.

Analysts Set New Price Targets

Analysts maintain a consensus rating of 'strong buy' for AdaptHealth. On September 17, 2026, Baird maintained an 'Outperform' rating with a price target of $9.00. UBS also kept a 'Buy' rating with a target of $10.00, while RBC Capital maintained an 'Outperform' rating with a target of $8.00. These ratings suggest a favorable outlook for the company, despite mixed target adjustments in recent months.

What AHCO Does

AdaptHealth Corp. distributes home medical equipment and related services across the United States. The company operates in various segments, including Sleep Health and Respiratory Health, catering to patients with chronic conditions. The ongoing insider buying could indicate that company leaders are optimistic about its future in the healthcare market.

What’s Next for AdaptHealth

Investors will be watching closely for the next earnings report, scheduled for November 3, 2026. Recent insider transactions reflect past actions and may not indicate current positions. As AdaptHealth continues to navigate the healthcare landscape, further developments will be significant for its shareholders.